Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Oct 15;88(20):9340-4.
doi: 10.1073/pnas.88.20.9340.

Saccharide orientation at the cell surface affects glycolipid receptor function

Affiliations

Saccharide orientation at the cell surface affects glycolipid receptor function

N Strömberg et al. Proc Natl Acad Sci U S A. .

Abstract

Three allelic variants of P-pilus-associated G-adhesins (lectins) with different cell-binding properties were recently described. Here we have analyzed Escherichia coli HB101 strains expressing the recombinant G-adhesin variants for their ability to agglutinate erythrocytes from various species as this relates to the glycosphingolipid (GSL) composition in the erythrocyte membranes. All three variants exhibit similar specificities for the globo-series GSLs affixed to artificial surfaces. However, only the PapGJ96 adhesin induces agglutination of erythrocytes having globotriaosylceramide (GbO3) [Gal(alpha 1-4)LacCer] as the major GSL. Furthermore, only PapGAD110 induces strong agglutination of erythrocytes having globotetraosylceramide (GbO4) [GalNAc(beta 1-3)Gal(alpha 1-4)LacCer] as the major GSL, while PrsGJ96 alone agglutinates those containing globopentaosylceramide (GbO5) [GalNAc(alpha 1-3)GalNAc(beta 1-3)Gal(alpha 1-4)LacCer]. Molecular modeling of these globo-GSLs demonstrates different saccharide orientations to the membrane surface for these isoreceptors. We suggest that the differential binding of the three G-adhesin variants results from differences in epitope presentation at the membrane among these globo-GSLs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Mol Recognit. 1989 Nov;2(3):103-13 - PubMed
    1. Adv Cancer Res. 1989;52:257-331 - PubMed
    1. Methods Enzymol. 1987;138:220-32 - PubMed
    1. J Biol Chem. 1985 Jul 15;260(14):8545-51 - PubMed
    1. EMBO J. 1990 Jun;9(6):2001-10 - PubMed

LinkOut - more resources